Bromodomain inhibition of the coactivators CBP/EP300 facilitate cellular reprogramming
Silencing of the somatic cell type-specific genes is a critical yet poorly understood step in reprogramming. To uncover pathways that maintain cell identity, we performed a reprogramming screen using inhibitors of chromatin factors. Here, we identify acetyl-lysine competitive inhibitors targeting th...
Huvudupphovsmän: | Ebrahimi, A, Sevinç, K, Sevinç, G, Cribbs, A, Philpott, M, Uyulur, F, Morova, T, Dunford, J, Göklemez, S, Arı, Ş, Oppermann, U, Onder, T |
---|---|
Materialtyp: | Journal article |
Publicerad: |
Springer Nature
2019
|
Liknande verk
Liknande verk
-
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma
av: Andrew R Conery, et al.
Publicerad: (2016-01-01) -
Correction: Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma
av: Andrew R Conery, et al.
Publicerad: (2016-07-01) -
Discovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains
av: Hay, D, et al.
Publicerad: (2014) -
Development of selective CBP/P300 benzoxazepine bromodomain inhibitors
av: Popp, T, et al.
Publicerad: (2016) -
CBP/p300 bromodomain: new promising epigenetic target
av: Xiang Qiuping, et al.
Publicerad: (2022-01-01)